SCHEMBL5763194

SCHEMBL5763194

O=c1[nH]c(=S)[nH]nc1C1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.39
▸ PDE1A P54750 1/20 0.39
▸ PDE1B Q01064 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE1C Q14123 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HPGD P15428 2/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ JAK2 O60674 6/20 0.33
▸ JAK1 P23458 6/20 0.33
▸ TYK2 P29597 6/20 0.33
▸ JAK3 P52333 6/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ DAO P14920 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13455320 0.98 PDE5A (0.41) PDE5APDE1APDE1BPDE3BPDE1C
SCHEMBL17272791 0.92 ALDH1A1 (0.37) PDE5APDE1APDE1BPDE3BPDE1C
SCHEMBL22077239 0.75 LMNA (0.36) PDE5APDE1APDE1BPDE3BPDE1C
SCHEMBL6366219 0.66 ADORA1 (0.43) PDE5APDE1APDE1BPDE3BPDE1C
SCHEMBL1786994 0.66 PRMT5 (0.48) ALDH1A1LMNAPOLBCYP2C9MAPT
SCHEMBL1790181 0.65 PRMT5 (0.47) ALDH1A1LMNAPOLBCYP2C9KDM4E
SCHEMBL17383088 0.64 MAPT (0.41) ALDH1A1POLBJAK2JAK1TYK2
SCHEMBL13219745 0.64 TXN (0.36) PDE5APDE1APDE1BPDE3BPDE1C
SCHEMBL16082062 0.63 ADORA2A (0.38) ALDH1A1LMNAPOLBHPGDJAK2
SCHEMBL1786583 0.62 ATM (0.47) ALDH1A1LMNAPOLBCYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644353-A1 AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES Bayer HealthCare AG (DE) 2006-04-12 — — EP disclosed
WO-2005003118-A1 AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES BAYER HEALTHCARE AG (DE) 2005-01-13 — — WO disclosed
Send feedback